More Info for Industries.
Industrial goalsThe VPHOP starts on 1st September 2008.
Commercial exploitation plans will be defined in detail only after the first concrete results are achieved.
At this stage we can foresee a number of potentially marketable innovations, including:
- Imaging technology to generate whole bone patient-specific models with
very low dose
- Wearable activity monitor capable of capturing patient life style
for one week including para-physiological events
- Hypermodelling technology for the creation of massive multiscale
models using heterogeneous codes
- Data sharing and translation services for large biomedical and
simulation datasets
- Software technology for the patient-specific deterministic prediction of
the absolute risk of fracture
- Tissue level, in vivo imaging at spine and hip with clinically acceptable
doses
- Cellular activity models, capable of predicting the functional outcome
of different pharmacological modulations of the bone metabolism.
More info
If you wish to have more information on the VPHOP innovations and technologies and the developments of the project please visit
usInterested?
Do you want to join the Industrial Board as external member? contact us